Weighted Average Number of Shares Outstanding, Diluted of Alzamend Neuro, Inc. from 31 Jul 2021 to 31 Jan 2026

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Alzamend Neuro, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 31 Jul 2021 to 31 Jan 2026.
  • Alzamend Neuro, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 31 Jan 2026 was 3,804,741, a 522% increase year-over-year.
  • Alzamend Neuro, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 450,799, a 508% increase from 2023.
  • Alzamend Neuro, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 74,174, a 89% decline from 2022.
  • Alzamend Neuro, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 650,126, a 99% decline from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

Alzamend Neuro, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 3,804,741 +3,192,763 +522% 01 Nov 2025 31 Jan 2026 10-Q 11 Mar 2026 2026 Q3
Q3 2025 3,380,968 +2,988,557 +762% 01 Aug 2025 31 Oct 2025 10-Q 09 Dec 2025 2026 Q2
Q2 2025 2,106,036 +2,020,722 +2369% 01 May 2025 31 Jul 2025 10-Q 10 Sep 2025 2026 Q1
Q1 2025 450,799 +376,625 +508% 01 Feb 2025 30 Apr 2025 10-K 22 Jul 2025 2025 FY
Q4 2024 611,978 -93,454 -13% 01 Nov 2024 31 Jan 2025 10-Q 11 Mar 2026 2026 Q3
Q3 2024 392,411 -263,967 -40% 01 Aug 2024 31 Oct 2024 10-Q 09 Dec 2025 2026 Q2
Q2 2024 85,314 -570,953 -87% 01 May 2024 31 Jul 2024 10-Q 10 Sep 2025 2026 Q1
Q1 2024 74,174 -575,952 -89% 01 Feb 2024 30 Apr 2024 10-K 22 Jul 2025 2025 FY
Q4 2023 705,432 -5,849,646 -89% 01 Nov 2023 31 Jan 2024 10-Q 10 Mar 2025 2024 Q3
Q3 2023 656,378 -5,842,852 -90% 01 Aug 2023 31 Oct 2023 10-Q 11 Dec 2024 2024 Q2
Q2 2023 656,267 -96,825,523 -99% 01 May 2023 31 Jul 2023 10-Q 11 Sep 2024 2024 Q1
Q1 2023 650,126 -88,445,148 -99% 01 Feb 2023 30 Apr 2023 10-K 30 Jul 2024 2024 FY
Q4 2022 6,555,078 -87,610,147 -93% 01 Nov 2022 31 Jan 2023 10-Q 25 Mar 2024 2024 Q3
Q3 2022 6,499,230 -86,959,326 -93% 01 Aug 2022 31 Oct 2022 10-Q 15 Dec 2023 2024 Q2
Q2 2022 97,481,790 +12,893,298 +15% 01 May 2022 31 Jul 2022 10-Q 13 Sep 2023 2024 Q1
Q1 2022 89,095,274 01 Feb 2022 30 Apr 2022 10-K 27 Jul 2023 2023 FY
Q4 2021 94,165,225 01 Nov 2021 31 Jan 2022 10-Q 15 Mar 2023 2023 Q3
Q3 2021 93,458,556 01 Aug 2021 31 Oct 2021 10-Q 12 Dec 2022 2022 Q2
Q2 2021 84,588,492 01 May 2021 31 Jul 2021 10-Q 13 Sep 2022 2022 Q1

Alzamend Neuro, Inc. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 450,799 +376,625 +508% 01 May 2024 30 Apr 2025 10-K 22 Jul 2025 2025 FY
2023 74,174 -575,952 -89% 01 May 2023 30 Apr 2024 10-K 22 Jul 2025 2025 FY
2022 650,126 -88,445,148 -99% 01 May 2022 30 Apr 2023 10-K 30 Jul 2024 2024 FY
2021 89,095,274 01 May 2021 30 Apr 2022 10-K 27 Jul 2023 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.